Ahead Therapeutics SL has received positive feedback from the EMA on its way toward initiating regulatory toxicology studies for its lead program in myasthenia gravis. The feedback supports the ...

The Food and Drug Administration (FDA) has approved Imaavy™ (nipocalimab-aahu) for the treatment of generalized myasthenia gravis (gMG) in adult and pediatric patients aged 12 years and older who are ...

The US Food and Drug Administration has approved nipocalimab-aahu, a new FcRn- blocking monoclonal antibody, for the ...

AI model for thyroid cancer diagnosis, with over 90% accuracy and reduced consultation preparation time Date: April 25, 2025 Source: The University of Hong Kong Summary: An interdisciplinary ...

The Ministry of Food and Drug Safety noted on the 24th that it will approve the use of the systemic Myasthenia Gravis treatment, Listigoju (Rozanolixizumab). Myasthenia Gravis is a rare disease ...

Molecular evidence suggested a link between HPV and thyroid eye disease in a small study. Orbital tissue samples showed elevated HPV18 L1 IgG titers in those with chronic or acute active thyroid ...

As for the FcRn franchise - Myasthenia Gravis first - estimates indicate ... Rheumatoid Arthritis, Thyroid Eye Disease, and other potential expansion indications for Brepocitinib and all ...

Panel B is adapted from Pyzik et al. 4 Panel A shows the mean change in the Myasthenia Gravis–Activities of Daily Living (MG-ADL) score (blue circles; higher scores indicate more severe disease ...

According to Shruti K Bhardwaj, Chief Clinical Nutritionist at Zydus Hospitals, Thaltej, Ahmedabad, “The thyroid gland is deeply dependent on specific nutrients to function optimally. Even with ...

MG-ADL scores improved, indicating enhanced daily functioning for patients with myasthenia gravis. Limitations include potential coding errors, selection biases, and missing clinical data ...